Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure
| dc.contributor.author | Shingde, R.V. | |
| dc.contributor.author | Reuter, S.E. | |
| dc.contributor.author | Graham, G.G. | |
| dc.contributor.author | Carland, J.E. | |
| dc.contributor.author | Williams, K.M. | |
| dc.contributor.author | Day, R.O. | |
| dc.contributor.author | Stocker, S.L. | |
| dc.date.issued | 2020 | |
| dc.description | Data source: Supplementary date, https://doi.org/10.1093/jac/dkaa320 | |
| dc.description.abstract | Background: Current guidelines for intravenous vancomycin identify drug exposure (as indicated by the AUC) as the best pharmacokinetic (PK) indicator of therapeutic outcome. Objectives: To assess the accuracy of two Bayesian forecasting programs in estimating vancomycin AUC0–1 in adults with limited blood concentration sampling. Methods: The application of seven vancomycin population PK models in two Bayesian forecasting programs was examined in non-obese adults (n = 22) with stable renal function. Patients were intensively sampled following a single (1000 mg or 15 mg/kg) dose. For each patient, AUC was calculated by fitting all vancomycin concentrations to a two-compartment model (defined as AUCTRUE). AUCTRUE was then compared with the Bayesian-estimated AUC0–1 values using a single vancomycin concentration sampled at various times post-infusion. Results: Optimal sampling times varied across different models. AUCTRUE was generally overestimated at earlier sampling times and underestimated at sampling times after 4 h post-infusion. The models by Goti et al. (Ther Drug Monit 2018; 40: 212–21) and Thomson et al. (J Antimicrob Chemother 2009; 63: 1050–7) had precise and unbiased sampling times (defined as mean imprecision <25% and <38 mgh/L, with 95% CI for mean bias containing zero) between 1.5 and 6 h and between 0.75 and 2 h post-infusion, respectively. Precise but biased sampling times for Thomson et al. were between 4 and 6 h post-infusion. Conclusions: When using a single vancomycin concentration for Bayesian estimation of vancomycin drug exposure (AUC), the predictive performance was generally most accurate with sample collection between 1.5 and 6 h after infusion, though optimal sampling times varied across different population PK models. | |
| dc.identifier.citation | Journal of Antimicrobial Chemotherapy, 2020; 75(11):3239-3302 | |
| dc.identifier.doi | 10.1093/jac/dkaa320 | |
| dc.identifier.issn | 0305-7453 | |
| dc.identifier.issn | 1460-2091 | |
| dc.identifier.uri | https://hdl.handle.net/11541.2/146015 | |
| dc.language.iso | en | |
| dc.publisher | Oxford University Press | |
| dc.rights | Copyright 2020 The author(s). Published by Oxford University Press | |
| dc.source.uri | https://doi.org/10.1093/jac/dkaa320 | |
| dc.subject | intravenous vancomycin | |
| dc.subject | Bayesian estimation | |
| dc.subject | post-infusion | |
| dc.title | Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure | |
| dc.type | Journal article | |
| pubs.publication-status | Published | |
| ror.mmsid | 9916458211501831 |